Business of Biotech 201: From Molecule to Market, R&D and Regulatory Considerations (October 2021)
Member Rate applies for MassBio Member Company, Other State Bioscience Association Member Company, MassCONNECT Company, or Unemployed Individual
If you are registered for Business of Biotech 101 or have taken the course in the past year, you are eligible to receive a 10% discount applied to your registration of Business of Biotech 201. Contact firstname.lastname@example.org to obtain the coupon code to enter when checking out.
Business of Biotech 201: From Molecule to Market, R&D And Regulatory Considerations builds on the business overview of the “Business of Biotech 101” course. This course delivers an outline of clinical, regulatory, and quality considerations and practices. Attendees will be provided foundational information about the Biopharma industry and regulations via instruction, storytelling, and breakout group discussions. Applied industry ethics will be discussed with emphasis on historical precedents. The course will explore the decision-making process by touching on relevant topics such as market share and phases of development.
Monday, October 18th, 2021 02:30-05:00 PM EST
Tuesday, October 19th, 2021 02:30-05:00 PM EST
Thursday, October 21st, 2021 02:30-05:00 PM EST
The History of Regulations
Research & Development: An Overview of R&D
Roles in Clinical Trials
Compliance via Regulatory & Quality Processes